Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Trace elements in ALS patients and their relationships with clinical severity.

Oggiano R, Solinas G, Forte G, Bocca B, Farace C, Pisano A, Sotgiu MA, Clemente S, Malaguarnera M, Fois AG, Pirina P, Montella A, Madeddu R.

Chemosphere. 2018 Apr;197:457-466. doi: 10.1016/j.chemosphere.2018.01.076. Epub 2018 Jan 16.

PMID:
29366958
2.

Essential trace elements in amyotrophic lateral sclerosis (ALS): Results in a population of a risk area of Italy.

Forte G, Bocca B, Oggiano R, Clemente S, Asara Y, Sotgiu MA, Farace C, Montella A, Fois AG, Malaguarnera M, Pirina P, Madeddu R.

Neurol Sci. 2017 Sep;38(9):1609-1615. doi: 10.1007/s10072-017-3018-2. Epub 2017 Jun 10.

PMID:
28601974
3.

Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy.

Dell'Avvento S, Sotgiu MA, Manca S, Sotgiu G, Sotgiu S.

Eur J Pediatr. 2016 Jan;175(1):19-29. doi: 10.1007/s00431-015-2588-3. Epub 2015 Jul 10.

PMID:
26156052
4.

Cerebrotendinous xanthomatosis: recurrence of the CYP27A1 mutation p.Arg479Cys in Sardinia.

Mandrile G, Gallus GN, Mura G, Di Sapio A, Sotgiu MA, Montella A, Giachino DF, Dotti MT, Ulgheri L, Federico A.

Neurol Sci. 2014 Aug;35(8):1303-5. doi: 10.1007/s10072-014-1696-6. Epub 2014 Mar 2. No abstract available.

5.

ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations.

Chiò A, Restagno G, Brunetti M, Ossola I, Calvo A, Canosa A, Moglia C, Floris G, Tacconi P, Marrosu F, Marrosu MG, Murru MR, Majounie E, Renton AE, Abramzon Y, Pugliatti M, Sotgiu MA, Traynor BJ, Borghero G; SARDINIALS Consortium.

J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):730-3. doi: 10.1136/jnnp-2012-302219. Epub 2012 May 1.

6.

Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells.

Asara Y, Marchal JA, Bandiera P, Mazzarello V, Delogu LG, Sotgiu MA, Montella A, Madeddu R.

Eur J Histochem. 2012 Jan 20;56(1):e1. doi: 10.4081/ejh.2012.e1.

7.

C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.

Sabatelli M, Conforti FL, Zollino M, Mora G, Monsurrò MR, Volanti P, Marinou K, Salvi F, Corbo M, Giannini F, Battistini S, Penco S, Lunetta C, Quattrone A, Gambardella A, Logroscino G, Simone I, Bartolomei I, Pisano F, Tedeschi G, Conte A, Spataro R, La Bella V, Caponnetto C, Mancardi G, Mandich P, Sola P, Mandrioli J, Renton AE, Majounie E, Abramzon Y, Marrosu F, Marrosu MG, Murru MR, Sotgiu MA, Pugliatti M, Rodolico C; ITALSGEN Consortium, Moglia C, Calvo A, Ossola I, Brunetti M, Traynor BJ, Borghero G, Restagno G, Chiò A.

Neurobiol Aging. 2012 Aug;33(8):1848.e15-20. doi: 10.1016/j.neurobiolaging.2012.02.011. Epub 2012 Mar 13.

8.

Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.

Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, Sendtner M, Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG, Marrosu F, Marinou K, Mandrioli J, Sola P, Caponnetto C, Mancardi G, Mandich P, La Bella V, Spataro R, Conte A, Monsurrò MR, Tedeschi G, Pisano F, Bartolomei I, Salvi F, Lauria Pinter G, Simone I, Logroscino G, Gambardella A, Quattrone A, Lunetta C, Volanti P, Zollino M, Penco S, Battistini S; ITALSGEN consortium, Renton AE, Majounie E, Abramzon Y, Conforti FL, Giannini F, Corbo M, Sabatelli M.

Brain. 2012 Mar;135(Pt 3):784-93. doi: 10.1093/brain/awr366.

9.

Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis.

Madeddu R, Farace C, Tolu P, Solinas G, Asara Y, Sotgiu MA, Delogu LG, Prados JC, Sotgiu S, Montella A.

Neurol Sci. 2013 Feb;34(2):181-6. doi: 10.1007/s10072-012-0974-4. Epub 2012 Feb 24.

PMID:
22362332
10.

Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients.

Pugliatti M, Riise T, Nortvedt MW, Carpentras G, Sotgiu MA, Sotgiu S, Rosati G.

J Neurol. 2008 Feb;255(2):157-62. doi: 10.1007/s00415-008-0543-1. Epub 2008 Feb 20.

PMID:
18283408
11.

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population.

Pugliatti M, Riise T, Sotgiu MA, Satta WM, Sotgiu S, Pirastru MI, Rosati G.

Am J Epidemiol. 2006 Aug 15;164(4):326-33. Epub 2006 Jun 5.

PMID:
16754634
12.

Seasonal fluctuation of multiple sclerosis births in Sardinia.

Sotgiu S, Pugliatti M, Sotgiu MA, Fois ML, Arru G, Sanna A, Rosati G.

J Neurol. 2006 Jan;253(1):38-44. Epub 2005 Jul 20.

PMID:
16021348
13.

Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia.

Pugliatti M, Riise T, Sotgiu MA, Sotgiu S, Satta WM, Mannu L, Sanna G, Rosati G.

Neuroepidemiology. 2005;25(3):129-34. Epub 2005 Jun 29.

PMID:
15990443
14.

Genes, environment, and susceptibility to multiple sclerosis.

Sotgiu S, Pugliatti M, Fois ML, Arru G, Sanna A, Sotgiu MA, Rosati G.

Neurobiol Dis. 2004 Nov;17(2):131-43. Review.

PMID:
15474351
15.

Multiple sclerosis in Northern Sardinia, Italy: a methodological approach for genetic epidemiological studies.

Pugliatti M, Sotgiu S, Sadovnick AD, Yee IM, Sotgiu MA, Poser CM, Rosati G.

Neuroepidemiology. 2003 Nov-Dec;22(6):362-5.

PMID:
14557688

Supplemental Content

Loading ...
Support Center